Launched in Spain and Colombia in 2020, myBIOME is an innovative gut microbiome examination based on technology developed by Microba’s leading researchers in the field of microbiome analysis. The ...

PARIS--(BUSINESS WIRE)--Regulatory News: Ikonisys (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for ...

BERLIN, April 7 (Reuters) - Laboratory services group Synlab announced plans on Wednesday to float shares on the German stock market, offering investors exposure to the coronavirus testing boom and ...

Buyout fund Cinven has launched preparations for a potential stock market listing of German laboratory services group Synlab, while also sounding out potential buyers for a 5.5 billion euro ($6 ...

Cinven has made an indicative offer to take Synlab AG private in a roughly €2.2 billion ($2.4 billion) deal, just two years after listing the German laboratory operator that’s now battling with ...

FRANKFURT (Reuters) - German laboratory services group Synlab is pushing ahead with preparations for a planned stock market listing next year and has drafted banks to organise the deal, people close ...

(Reuters) – Buyout group BC Partners has put German laboratory operator Synlab up for sale in a potential deal worth more than 1.5 billion euros ($1.6 billion), three people familiar with the matter ...

ESG Report 2021: SYNLAB defines high-impact areas to drive its ambitious environmental, social and governance agenda 29.04.2022 / 08:00 The issuer is solely responsible for the content of this ...

Synlab Italia has suspended all its medical diagnostic and testing services after a ransomware attack forced its IT systems to be taken offline. Part of the Synlab group that is present in 30 ...

As Nigeria continues to battle the persistent challenge of HIV/AIDS, social stigma remains one of the most significant obstacles to early detection and effective treatment. Many Nigerians still avoid ...